PO Box 58871
London SE15 9BE, UK
+44 (0)7794 485294

Evidence & Efficacy: Angiotensin II Receptor Antagonists

Advisory board: TBC


Trial categories will include the following:
Major trials of ARBs in primary prevention of hypertension
Major trials of ARBs in secondary prevention of hypertension and target-organ damage
Trials of ARBs that achieve 24-hour control of hypertension
Reducing blood pressure and absolute cardiovascular risk
Major trials of ARBs in secondary prevention of heart failure
Trials of ARBs in hypertensive patients with type 2 diabetes mellitus (diabetic hypertension)
Prevention of the progression of chronic (nondiabetic) kidney disease using ARBs
Prevention of the progression of diabetic nephropathy (diabetic kidney disease) using ARBs
Comparative antihypertensive efficacy trials of ARBs

If you are interested in this title, you might also be interested in the following titles:
The 10-minute consultation: hypertension
Quit Smoking Wheel


  • Paperback: 80 pages
  • Published: 01 Jan 2017
  • Languages: English
  • Product dimensions: 148 x 210 mm (6.5 x 8.25 inches)

Rights Availability

If you have an enquiry about the availability of foreign language rights or permissions, please contact us


Download the sales sheet, request an advance reading copy or order

Academics and Librarians

Request an inspection copy


Cedilla Publishing Limited, PO Box 58871, London SE15 9BE, United Kingdom. Tel: +44 (0)7794 485294. Email: info@cedillapublishing.com
All site content ©2006-2022 Cedilla Publishing Limited. All rights reserved. Cookies & Privacy.